Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. Amneal Pharmaceuticals, Inc. (AMRX) Added to S&P SmallCap 600 Index, Boosting Investor Visibility The next stock on our list is Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX). TheFly reported on Feb 11 that JP Morgan raised AMRX price target by $4 and maintained a Buy rating. Separately, on January 29, Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced that it would be added to the S&P S ...

Core Viewpoint - KeifeRx has entered into a research collaboration and option agreement with Amneal Pharmaceuticals to advance the pre-IND development of KFRX06, a candidate targeting LRRK2 for Parkinson's disease [1] Company Summary - KeifeRx is a privately held biotechnology company focused on developing disease-modifying therapies for neurodegenerative disorders [1] - KFRX06 is a preclinical candidate aimed at inhibiting the LRRK2 gene, which is significantly associated with Parkinson's disease [1] Industry Summary - The collaboration with Amneal Pharmaceuticals is intended to support the pre-IND development phase, indicating a strategic partnership to enhance research capabilities in the neurodegenerative disorder space [1]